JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.5B
| $43.2M | 0.01% |
516,515
-45,920
| -8% | -$3.76M |
|
1052
Agnico Eagle Mines
AEM
$90.5B
| $43M | 0.01% |
931,950
-350,737
| -27% | -$15.7M |
|
|
ODP
1053
DELISTED
ODP
ODP
| $43M | 0.01% |
1,214,928
-12,138
| -1% | -$420K |
|
1054
American Financial Group
AFG
$12.1B
| $42.9M | 0.01% |
395,455
-72,151
| -15% | -$7.57M |
|
|
QCP
1055
DELISTED
Quality Care Properties, Inc.
QCP
| $42.6M | 0.01% |
3,087,230
-1,034,802
| -25% | -$15.8M |
|
1056
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.76B
| $42.5M | 0.01% |
1,430,555
+40,746
| +3% | +$1.21M |
|
1057
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
| $42.5M | 0.01% |
1,335,773
-615,375
| -32% | -$19.5M |
|
|
EE
1058
DELISTED
El Paso Electric Company
EE
| $42.3M | 0.01% |
763,625
-9,410
| -1% | -$546K |
|
1059
VanEck Gold Miners ETF
GDX
$27.4B
| $42.2M | 0.01% |
1,815,964
+726,268
| +67% | +$16.5M |
|
1060
CALL
Chevron
CVX
$366B
| $42.2M | 0.01% |
337,100
-110,400
| -25% | -$13.1M |
|
1061
Neurocrine Biosciences
NBIX
$16.6B
| $42.1M | 0.01% |
542,579
+12,331
| +2% | +$841K |
|
1062
FTI Consulting
FCN
$4.18B
| $41.7M | 0.01% |
971,476
+204,433
| +27% | +$8.34M |
|
1063
CALL
American Airlines Group
AAL
$10.6B
| $41.6M | 0.01% |
799,500
+271,000
| +51% | +$13.5M |
|
1064
PUT
Procter & Gamble
PG
$339B
| $41.6M | 0.01% |
452,600
+84,700
| +23% | +$7.62M |
|
1065
RenaissanceRe
RNR
$13.4B
| $41.6M | 0.01% |
330,867
-169,654
| -34% | -$22.8M |
|
1066
NOV
NOV
$7B
| $41.5M | 0.01% |
1,152,136
+786,930
| +215% | +$26.6M |
|
1067
Antero Resources
AR
$10.7B
| $41.5M | 0.01% |
2,182,882
+397,163
| +22% | +$7.62M |
|
|
SRC
1068
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $41.5M | 0.01% |
1,077,927
+186,218
| +21% | +$7.07M |
|
1069
Cooper Companies
COO
$14.5B
| $41.4M | 0.01% |
760,620
-54,716
| -7% | -$3.2M |
|
1070
PUT
Goldman Sachs
GS
$303B
| $41.4M | 0.01% |
162,500
-121,300
| -43% | -$29.8M |
|
1071
Broadridge
BR
$19B
| $41.3M | 0.01% |
455,944
-47,520
| -9% | -$4.15M |
|
|
AGN.PRA
1072
DELISTED
Allergan plc
AGN.PRA
| $41.3M | 0.01% |
70,404
+27,490
| +64% | +$17.7M |
|
1073
Zoetis
ZTS
$30B
| $41.1M | 0.01% |
570,765
+53,414
| +10% | +$3.67M |
|
1074
REX American Resources
REX
$1.41B
| $41M | 0.01% |
2,973,666
+103,980
| +4% | +$1.52M |
|
|
CYS
1075
DELISTED
CYS Investments Inc.
CYS
| $41M | 0.01% |
5,104,184
-144,182
| -3% | -$1.19M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.